CN116064495B - THDP dependent decarboxylase and application thereof - Google Patents
THDP dependent decarboxylase and application thereof Download PDFInfo
- Publication number
- CN116064495B CN116064495B CN202211195258.2A CN202211195258A CN116064495B CN 116064495 B CN116064495 B CN 116064495B CN 202211195258 A CN202211195258 A CN 202211195258A CN 116064495 B CN116064495 B CN 116064495B
- Authority
- CN
- China
- Prior art keywords
- decarboxylase
- furanyl
- furfural
- present
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000001419 dependent effect Effects 0.000 title claims abstract description 8
- HYBBIBNJHNGZAN-UHFFFAOYSA-N Furaldehyde Natural products O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 claims abstract description 48
- RSZZMVPSHLKFQY-UHFFFAOYSA-N 1-(furan-2-yl)-2-hydroxyethanone Chemical compound OCC(=O)C1=CC=CO1 RSZZMVPSHLKFQY-UHFFFAOYSA-N 0.000 claims abstract description 42
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims abstract description 30
- 239000000758 substrate Substances 0.000 claims abstract description 18
- 239000003054 catalyst Substances 0.000 claims description 9
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 5
- 238000003786 synthesis reaction Methods 0.000 claims description 5
- 238000006555 catalytic reaction Methods 0.000 abstract description 18
- 108090000623 proteins and genes Proteins 0.000 abstract description 17
- JHMIHJYIJSMCQH-UHFFFAOYSA-N azane;furan Chemical compound N.C=1C=COC=1 JHMIHJYIJSMCQH-UHFFFAOYSA-N 0.000 abstract description 15
- 230000003197 catalytic effect Effects 0.000 abstract description 12
- 102000004169 proteins and genes Human genes 0.000 abstract description 9
- 241000894006 Bacteria Species 0.000 abstract description 8
- 239000002243 precursor Substances 0.000 abstract description 6
- 238000002360 preparation method Methods 0.000 abstract description 6
- 239000007791 liquid phase Substances 0.000 abstract description 5
- 239000013604 expression vector Substances 0.000 abstract description 4
- 238000010485 C−C bond formation reaction Methods 0.000 abstract description 2
- 230000001939 inductive effect Effects 0.000 abstract description 2
- 230000002194 synthesizing effect Effects 0.000 abstract description 2
- 230000001131 transforming effect Effects 0.000 abstract description 2
- 108090000489 Carboxy-Lyases Proteins 0.000 description 44
- 102000004031 Carboxy-Lyases Human genes 0.000 description 41
- 239000000047 product Substances 0.000 description 29
- 238000006243 chemical reaction Methods 0.000 description 19
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 239000007864 aqueous solution Substances 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- 238000004128 high performance liquid chromatography Methods 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- IEMMBWWQXVXBEU-UHFFFAOYSA-N 2-acetylfuran Chemical compound CC(=O)C1=CC=CO1 IEMMBWWQXVXBEU-UHFFFAOYSA-N 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 229940041514 candida albicans extract Drugs 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 239000012137 tryptone Substances 0.000 description 5
- 239000012138 yeast extract Substances 0.000 description 5
- FXBWJHBHNXGJBU-UHFFFAOYSA-N 1,3-bis(furan-2-yl)-1,3-dihydroxypropan-2-one Chemical compound C=1C=COC=1C(O)C(=O)C(O)C1=CC=CO1 FXBWJHBHNXGJBU-UHFFFAOYSA-N 0.000 description 4
- 238000007259 addition reaction Methods 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- 240000000220 Panda oleosa Species 0.000 description 2
- 235000016496 Panda oleosa Nutrition 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- RHDGNLCLDBVESU-UHFFFAOYSA-N but-3-en-4-olide Chemical compound O=C1CC=CO1 RHDGNLCLDBVESU-UHFFFAOYSA-N 0.000 description 2
- JFPVXVDWJQMJEE-IZRZKJBUSA-N cefuroxime Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(O)=O)=O)C(=O)\C(=N/OC)C1=CC=CO1 JFPVXVDWJQMJEE-IZRZKJBUSA-N 0.000 description 2
- 229960001668 cefuroxime Drugs 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000005755 formation reaction Methods 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000012807 shake-flask culturing Methods 0.000 description 2
- SMNDYUVBFMFKNZ-UHFFFAOYSA-N 2-furoic acid Chemical compound OC(=O)C1=CC=CO1 SMNDYUVBFMFKNZ-UHFFFAOYSA-N 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- 239000012880 LB liquid culture medium Substances 0.000 description 1
- GMPKIPWJBDOURN-UHFFFAOYSA-N Methoxyamine Chemical compound CON GMPKIPWJBDOURN-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- FXPPGVHVOSTDOE-UHFFFAOYSA-N O1C(=CC=C1)C(CO)C(=O)C(CO)C=1OC=CC1 Chemical compound O1C(=CC=C1)C(CO)C(=O)C(CO)C=1OC=CC1 FXPPGVHVOSTDOE-UHFFFAOYSA-N 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010183 spectrum analysis Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/04—Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
本发明属于生物工程领域,具体涉及一种THDP依赖型脱羧酶及其在制备呋喃铵盐前体中的应用,具体的应用是,上述脱羧酶能高效催化糠醛和甲醛C‑C键形成反应制备2‑呋喃基羟基甲基酮。本发明的脱羧酶由如下步骤制备获得:合成脱羧酶的编码基因,选择表达载体,转化蛋白表达宿主菌,诱导蛋白表达。本发明的脱羧酶具有极高的催化效率和底物耐受浓度,耐受的底物糠醛浓度的浓度可以达到60g/L,60g/L的糠醛浓度在20g/L的全细胞催化下6h之内可以反应完全,产物液相纯度能够达到97.26%,2‑呋喃基羟基甲基酮最高产量达到80g/L。
The present invention belongs to the field of bioengineering, and is particularly related to a THDP-dependent decarboxylase and its application in the preparation of furan ammonium salt precursors, and the specific application is that the above-mentioned decarboxylase can efficiently catalyze furfural and formaldehyde C-C bond formation reaction to prepare 2-furanyl hydroxymethyl ketone. The decarboxylase of the present invention is prepared by the following steps: synthesizing the coding gene of the decarboxylase, selecting an expression vector, transforming the protein expression host bacteria, and inducing protein expression. The decarboxylase of the present invention has extremely high catalytic efficiency and substrate tolerance concentration, and the concentration of the tolerated substrate furfural concentration can reach 60g/L, and the furfural concentration of 60g/L can be completely reacted within 6h under the whole cell catalysis of 20g/L, and the product liquid phase purity can reach 97.26%, and the maximum yield of 2-furanyl hydroxymethyl ketone reaches 80g/L.
Description
技术领域Technical Field
本发明属于生物工程领域,具体涉及一种THDP依赖型脱羧酶及其在制备呋喃铵盐前体中的应用。The invention belongs to the field of bioengineering, and in particular relates to a THDP-dependent decarboxylase and application thereof in preparing a furanammonium salt precursor.
背景技术Background technique
呋喃铵盐是临床上运用很广的抗生素头孢呋辛的关键中间体之一,头孢呋辛是一种非经胃肠给药的半合成广谱头孢素菌类抗生素。目前呋喃铵盐的主流生产工艺是采用乙酰呋喃为原料首先经过氧化制得呋喃酮酸,再经甲氧胺肟化、通入氨气成盐得到呋喃铵盐。而现在市场销售的乙酰呋喃基本采用糠醛脱羰基制得呋喃,再用醋酐酰化制备乙酰呋喃。乙酰呋喃的原材料价格较高,随着市场竞争越来越激烈,导致呋喃铵盐的产品利润逐渐下滑,价格由2020年的每吨30万元左右下滑至目前的每吨18万元左右。如果以糠醛为原料经过脱羧酶一步制得2-呋喃基羟基甲基酮,然后再通过化学氧化制得呋喃铵盐中间体呋喃酮酸,用2-呋喃基羟基甲基酮替代乙酰呋喃用于呋喃铵盐的生产将显著降低呋喃铵盐的生产成本。工艺路线如下 (酶催化糠醛制备2-呋喃基羟基甲基酮的示意):Furan ammonium salt is one of the key intermediates of the widely used antibiotic cefuroxime in clinical practice. Cefuroxime is a semi-synthetic broad-spectrum cephalosporin antibiotic for parenteral administration. At present, the mainstream production process of furan ammonium salt is to use acetylfuran as a raw material to first oxidize to obtain furanone acid, and then oxime it with methoxyamine and introduce ammonia to form a salt to obtain furan ammonium salt. The acetylfuran currently sold on the market basically uses furan to be decarbonylated by furfural, and then acylated with acetic anhydride to prepare acetylfuran. The raw material price of acetylfuran is relatively high. With the increasingly fierce market competition, the product profit of furan ammonium salt has gradually declined, and the price has dropped from about 300,000 yuan per ton in 2020 to about 180,000 yuan per ton at present. If furfural is used as a raw material to obtain 2-furanyl hydroxymethyl ketone through a decarboxylase step, and then the furan ammonium salt intermediate furanone acid is obtained by chemical oxidation, using 2-furanyl hydroxymethyl ketone instead of acetylfuran for the production of furan ammonium salt will significantly reduce the production cost of furan ammonium salt. The process route is as follows (schematic diagram of the preparation of 2-furanyl hydroxymethyl ketone by enzyme-catalyzed furfural):
关于该工艺的相关报道,以下文献有过披露:The following documents have disclosed relevant reports on this process:
CN114591938A披露了一种羧化酶突变体及其制备方法和应用。其羧化酶突变体的氨基酸序列为SEQ ID NO:3SEQ ID NO:3是SEQ ID NO:1所示的氨基酸序列的第492位氨基酸由Val突变为Pro得到。其以糠醛和甲醛为原料生产呋喃铵盐前体物质1-(2-呋喃基)-2-羟基乙酮的高效催化,显著降低了呋喃铵盐的生产成本,产物1-(2-呋喃基)-2-羟基乙酮的纯度大大提高;其中,糠醛的浓度为20-60g/L,甲醛的浓度为20-60g/L,羧化酶突变体的用量为 8-12g/L;催化反应条件:温度为20-37℃,催化反应的pH=6.0-80,催化反应的时间为8-20h。CN114591938A discloses a carboxylase mutant and its preparation method and application. The amino acid sequence of the carboxylase mutant is SEQ ID NO:3. SEQ ID NO:3 is obtained by mutating the 492nd amino acid of the amino acid sequence shown in SEQ ID NO:1 from Val to Pro. The highly efficient catalysis of the production of furan ammonium salt precursor 1-(2-furanyl)-2-hydroxyethanone using furfural and formaldehyde as raw materials significantly reduces the production cost of furan ammonium salt, and the purity of the product 1-(2-furanyl)-2-hydroxyethanone is greatly improved; wherein, the concentration of furfural is 20-60g/L, the concentration of formaldehyde is 20-60g/L, and the dosage of the carboxylase mutant is 8-12g/L; the catalytic reaction conditions are: the temperature is 20-37°C, the pH of the catalytic reaction is 6.0-80, and the catalytic reaction time is 8-20h.
上述专利文献CN114591938A所披露的方法,虽然最终获得的呋喃铵盐前体物质1-(2-呋喃基)-2-羟基乙酮纯度较高,但是催化的时间略长,比如,该文献中披露,要获得纯度为97.1%的1-(2-呋喃基)-2-羟基乙酮,需要反应20小时,反应时间较长。The method disclosed in the above patent document CN114591938A, although the furan ammonium salt precursor 1-(2-furanyl)-2-hydroxyethanone finally obtained has a high purity, but the catalysis time is slightly longer. For example, the document discloses that to obtain 1-(2-furanyl)-2-hydroxyethanone with a purity of 97.1%, a reaction time of 20 hours is required, which is a long reaction time.
发明内容Summary of the invention
为了实现进一步提高催化效率和效果,缩短催化时间,本发明提供了一种能够更加高效催化糠醛与甲醛C-C键形成反应制备2-呋喃基羟基甲基酮的脱羧酶,相较于现有技术中的产品,其催化时间更短。In order to further improve the catalytic efficiency and effect and shorten the catalytic time, the present invention provides a decarboxylase that can more efficiently catalyze the C-C bond formation reaction of furfural and formaldehyde to prepare 2-furanyl hydroxymethyl ketone, and the catalytic time is shorter than that of the products in the prior art.
本发明中,利用分子克隆技术获得了脱羧酶的编码基因(SEQ ID NO:2),通过构建该酶基因的6×His融合表达载体并导入基因工程菌OverExpress C43(DE3)中诱导表达,获得了酶蛋白。以脱羧酶为催化剂、以糠醛和甲醛为底物在适当的条件下进行酶催化反应,结果表明,该酶合成的2-呋喃基羟基甲基酮纯度高,能够达到97.26%以上,最高产量达到60g/L,在呋喃铵盐的工业生产中有巨大的应用潜力和价值,并且其催化时间仅仅为6小时,相较于背景技术中所提及的CN114591938A中所披露的羧化酶突变体,大大节省了催化时间、提高了催化效率。In the present invention, the coding gene (SEQ ID NO: 2) of decarboxylase is obtained by molecular cloning technology, and the enzyme protein is obtained by constructing a 6×His fusion expression vector of the enzyme gene and introducing it into genetic engineering bacteria OverExpress C43 (DE3) to induce expression. The enzyme catalyzed reaction is carried out under appropriate conditions with decarboxylase as catalyst and furfural and formaldehyde as substrates. The results show that the 2-furanyl hydroxymethyl ketone synthesized by the enzyme has high purity, which can reach more than 97.26%, and the maximum yield reaches 60g/L. It has great application potential and value in the industrial production of furan ammonium salts, and its catalytic time is only 6 hours, which greatly saves catalytic time and improves catalytic efficiency compared to the carboxylase mutant disclosed in CN114591938A mentioned in the background technology.
本发明所提供的THDP依赖型脱羧酶,其氨基酸序列如SEQ ID NO:1所示;编码以上脱羧酶的核苷酸序列,如SEQ ID NO:2所示。The amino acid sequence of the THDP-dependent decarboxylase provided by the present invention is shown in SEQ ID NO: 1; the nucleotide sequence encoding the decarboxylase is shown in SEQ ID NO: 2.
包含上述核苷酸序列的表达盒、载体或重组菌,也同样在本发明所要保护的范围之内。The expression cassette, vector or recombinant bacteria containing the above nucleotide sequence are also within the scope of protection of the present invention.
上述的脱羧酶的制备方法,具体包括如下步骤:合成脱羧酶的编码基因,选择表达载体,转化蛋白表达宿主菌,诱导蛋白表达。The above-mentioned method for preparing the decarboxylase specifically comprises the following steps: synthesizing the coding gene of the decarboxylase, selecting an expression vector, transforming a protein expression host bacterium, and inducing protein expression.
上述的THDP依赖型脱羧酶在催化糠醛与甲醛C-C形成反应中的应用,是本发明所要重点保护的内容。The application of the above-mentioned THDP-dependent decarboxylase in catalyzing the C-C formation reaction of furfural and formaldehyde is the key content to be protected by the present invention.
具体的,上述脱羧酶在起催化作用时,是以糠醛和甲醛为底物进行的催化反应,可以用于催化合成2-呋喃基羟基甲基酮。上述的催化反应在 25-40℃、pH=6.0-7.0的条件下进行。Specifically, the above decarboxylase, when catalyzing, performs a catalytic reaction with furfural and formaldehyde as substrates, and can be used to catalyze the synthesis of 2-furanyl hydroxymethyl ketone. The above catalytic reaction is performed under the conditions of 25-40°C and pH=6.0-7.0.
含有上述脱羧酶的催化剂,以及该催化剂在催化糠醛与甲醛C-C形成反应中的应用,同样也是本发明所要保护的范围。具体的,上述催化剂的应用方法,同样也是以糠醛和甲醛为底物进行催化反应,合成2-呋喃基羟基甲基酮。上述催化反应也在25-40℃、pH=6.0-7.0条件下进行。The catalyst containing the above decarboxylase, and the use of the catalyst in catalyzing the C-C formation reaction between furfural and formaldehyde, are also within the scope of the present invention. Specifically, the application method of the above catalyst is also to carry out a catalytic reaction with furfural and formaldehyde as substrates to synthesize 2-furanyl hydroxymethyl ketone. The above catalytic reaction is also carried out under the conditions of 25-40°C and pH=6.0-7.0.
本发明的有益效果:Beneficial effects of the present invention:
(1)本发明通过生物学工程获取了一种脱羧酶,实现了以糠醛和甲醛为原料生产呋喃铵盐前体物质2-呋喃基羟基甲基酮的高效催化,具有极高的催化效率和底物耐受浓度,耐受的底物糠醛浓度可以达到60g/L,60g/L 的糠醛浓度在20g/L的全细胞催化下6h之内就可以反应完全,产物液相纯度能够达到97.26%,2-呋喃基羟基甲基酮最高产量达到80g/L;若是将其应用于工业化生产中,将显著降低呋喃铵盐的生产成本,具有极高的经济效益和价值;(1) The present invention obtains a decarboxylase through biological engineering, realizes the efficient catalysis of producing 2-furanyl hydroxymethyl ketone, a precursor of furan ammonium salt, using furfural and formaldehyde as raw materials, has extremely high catalytic efficiency and substrate tolerance concentration, and the tolerated substrate furfural concentration can reach 60 g/L. The 60 g/L furfural concentration can be completely reacted within 6 hours under the catalysis of 20 g/L whole cells, and the liquid phase purity of the product can reach 97.26%, and the maximum yield of 2-furanyl hydroxymethyl ketone reaches 80 g/L; if it is applied to industrial production, the production cost of furan ammonium salt will be significantly reduced, and it has extremely high economic benefits and value;
(2)与现有技术当中的催化剂相比,本发明的所提供的脱羧酶应用于催化中,与现有技术CN114591938A中催化剂相比,其催化效率更高,催化的时间更短,仅为CN114591938A中催化时间的1/3,相较于CN114591938A 中的催化剂,本发明具有显著的进步。(2) Compared with the catalysts in the prior art, the decarboxylase provided by the present invention is used in catalysis. Compared with the catalyst in the prior art CN114591938A, its catalytic efficiency is higher and the catalytic time is shorter, which is only 1/3 of the catalytic time in CN114591938A. Compared with the catalyst in CN114591938A, the present invention has significant progress.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1为脱羧酶的SDS-PAGE电泳图;其中,BL21(DE3)、Overexpress C43 (DE3)为2种E.coli蛋白表达宿主;Marker为蛋白质分子量标准;脱羧酶其分子量约为63.1kDa;Figure 1 is an SDS-PAGE electrophoresis diagram of decarboxylase; wherein BL21 (DE3) and Overexpress C43 (DE3) are two E. coli protein expression hosts; Marker is a protein molecular weight standard; the molecular weight of decarboxylase is about 63.1 kDa;
图2为脱羧酶催化生成产物的HPLC图谱;Fig. 2 is the HPLC collection of illustrative plates of the product generated by decarboxylase catalysis;
图3为脱羧酶催化生成产物的核磁共振图谱;(a)(b)依次为产物2-呋喃基羟基甲基酮标准品的H-NMR光谱、C-NMR光谱图;(c)(d)依次为脱羧酶全细胞催化生成产物2-呋喃基羟基甲基酮的H-NMR光谱、C-NMR光谱图。Figure 3 is the nuclear magnetic resonance spectrum of the product catalyzed by decarboxylase; (a) (b) are the H-NMR spectrum and C-NMR spectrum of the product 2-furanyl hydroxymethyl ketone standard respectively; (c) (d) are the H-NMR spectrum and C-NMR spectrum of the product 2-furanyl hydroxymethyl ketone catalyzed by the whole cell of decarboxylase respectively.
具体实施方式Detailed ways
下面结合具体实施例进一步描述本发明,需要声明的是,下述实施例仅作为解释和说明,不以任何方式限制本发明的范围。The present invention is further described below in conjunction with specific examples. It should be noted that the following examples are only for explanation and illustration and do not limit the scope of the present invention in any way.
主要试剂与耗材Main reagents and consumables
pET-28a(+)质粒为已知的大肠杆菌表达载体,载体大小为5369bp,T7 启动子,载体标签N-6×His和C-6×His,载体抗性Kanamycin(卡那霉素),购自Novogen公司;E.coliDH5α感受态细胞(货号:G6016),E.coli Overexpress C43(DE3)感受态细胞(货号:X17016)和E.coli BL21(DE3)感受态细胞 (货号:G6030),均购买自昂羽生物公司;琼脂粉(货号:A8190),购买值Solarbio公司;TRYPTONE(货号:LP0042)和YEAST EXTRACT(货号:LP0021)均购买自OXOID公司,NaCl(货号:10019318)、K2HPO4·3H2O(货号: 10017518)、KH2PO4(货号:10017618)和丙三醇(货号:10010618)等试剂均购买自国药集团化学试剂有限公司。pET-28a(+) plasmid is a known E. coli expression vector with a vector size of 5369 bp, T7 promoter, vector tags N-6×His and C-6×His, and vector resistance Kanamycin, purchased from Novogen; E. coli DH5α competent cells (Cat. No. G6016), E. coli Overexpress C43(DE3) competent cells (Cat. No. X17016) and E. coli BL21(DE3) competent cells (Cat. No. G6030) were all purchased from Ang Yu Biotechnology; agar powder (Cat. No. A8190) was purchased from Solarbio; TRYPTONE (Cat. No. LP0042) and YEAST EXTRACT (Cat. No. LP0021) were purchased from OXOID; NaCl (Cat. No. 10019318), K 2 HPO 4 ·3H 2 O (Cat. No. Reagents such as 1H 2 PO 4 (Cat. No. 10017518), KH 2 PO 4 (Cat. No. 10017618), and propylene glycol (Cat. No. 10010618) were purchased from Sinopharm Chemical Reagent Co., Ltd.
LB培养基LB medium
此处参考了专利文献CN114591938A。每100mL LB培养基含有:1g TRYPTONE、0.5gYEAST EXTRACT和1g NaCl,pH=7.0-7.2。配制方法:在1L 蒸馏水中溶解10g TRYPTONE、5gYEAST EXTRACT,10g NaCl,不调节pH值。若配制固体培养基,则100mL培养基中加入1.8g琼脂粉。121℃高压蒸汽灭菌20min。Patent document CN114591938A is referenced here. Each 100mL LB medium contains: 1g TRYPTONE, 0.5g YEAST EXTRACT and 1g NaCl, pH = 7.0-7.2. Preparation method: Dissolve 10g TRYPTONE, 5g YEAST EXTRACT, 10g NaCl in 1L distilled water, and do not adjust the pH value. If preparing solid culture medium, add 1.8g agar powder to 100mL culture medium. Sterilize with high pressure steam at 121℃ for 20min.
TB培养基TB medium
此处参考了专利文献CN114591938A。每100mL TB培养基含有:1.2g TRYPTONE、2.4g YEAST EXTRACT、0.4mL丙三醇、1.6g K2HPO4·3H2O和0.23 g KH2PO4,pH 7.0-7.2。配制方法:在1L蒸馏水中溶解12g TRYPTONE、24g YEAST EXTRACT、4mL丙三醇、16g K2HPO4·3H2O和2.3g KH2PO4,不调节pH 值。121℃高压蒸汽灭菌20min。Patent document CN114591938A is referenced here. Each 100 mL TB medium contains: 1.2 g TRYPTONE, 2.4 g YEAST EXTRACT, 0.4 mL glycerol, 1.6 g K 2 HPO 4 ·3H 2 O and 0.23 g KH 2 PO 4 , pH 7.0-7.2. Preparation method: Dissolve 12 g TRYPTONE, 24 g YEAST EXTRACT, 4 mL glycerol, 16 g K 2 HPO 4 ·3H 2 O and 2.3 g KH 2 PO 4 in 1 L of distilled water, and do not adjust the pH value. Sterilize with high pressure steam at 121°C for 20 min.
若未特别说明,以下实施例中使用的试剂均为本领域常规市售的试剂,可商购获得或按照本领域常规方法配制而得,规格为实验室纯级即可。若未特别说明,以下实施例中使用的方法均为本领域常规方法,使用的实验条件均为本领域常规实验条件,可参考相关实验手册或厂商说明书。Unless otherwise specified, the reagents used in the following examples are all commercially available reagents in the art, which can be obtained commercially or prepared according to conventional methods in the art, and the specifications are laboratory pure grade. Unless otherwise specified, the methods used in the following examples are all conventional methods in the art, and the experimental conditions used are all conventional experimental conditions in the art, and reference can be made to relevant experimental manuals or manufacturer instructions.
实施例1脱羧酶的制备Example 1 Preparation of decarboxylase
一、脱羧酶基因的获得及合成1. Acquisition and synthesis of decarboxylase gene
通过基因挖掘,从NCBI数据库中筛选获得了NCBI号为WP_103376266.1 的脱羧酶基因,该基因的开放阅读框全长1668bp,其编码的脱羧酶由555 个氨基酸组成,其氨基酸序列(555aa)见SEQ ID NO:1(序列表1);编码该脱羧酶的核苷酸序列见SEQ ID NO:2(序列表2);Through gene mining, a decarboxylase gene with NCBI number WP_103376266.1 was screened from the NCBI database. The open reading frame of the gene is 1668 bp in length. The decarboxylase encoded by the gene consists of 555 amino acids. The amino acid sequence (555aa) is shown in SEQ ID NO: 1 (Sequence Table 1); the nucleotide sequence encoding the decarboxylase is shown in SEQ ID NO: 2 (Sequence Table 2);
对Genbank ID为WP_103376266.1的脱羧酶进行全基因合成,合成后的基因片段连入pET-28a(+)质粒中。委托生工生物工程(上海)股份有限公司合成上述基因。The decarboxylase with Genbank ID WP_103376266.1 was fully synthesized, and the synthesized gene fragment was ligated into the pET-28a(+) plasmid. The above gene was synthesized by entrusting Sangon Biotech (Shanghai) Co., Ltd.
二、脱羧酶6×His融合蛋白的异源表达2. Heterologous Expression of Decarboxylase 6×His Fusion Protein
以下1-3的操作步骤参考了专利文献CN114591938A。The following operation steps 1-3 refer to patent document CN114591938A.
1、蛋白表达感受态细胞转化1. Transformation of competent cells for protein expression
从-80℃超低温冰箱中分别取出E.coli BL21(DE3)、E.coli Rosetta(DE3) 和Overexpress C43(DE3)、E.coli BL21-condon plus(DE3)感受态细胞,冰上放置。待细胞融化后,分别向每种感受态细胞中加入1μL含有脱羧酶基因的pET-28a(+)质粒,冰上放置30min。42℃热激50s,然后冰上放置3min。加入600μL无菌LB液体培养基,37℃,200rpm摇床培养1h。吸取200μL 培养好的菌液,涂布于含有Kana抗性(50μg/mL)的LB平板培养基上,37℃倒置培养过夜。Take out E.coli BL21(DE3), E.coli Rosetta(DE3), Overexpress C43(DE3), and E.coli BL21-condon plus(DE3) competent cells from the -80℃ ultra-low temperature freezer and place them on ice. After the cells melt, add 1μL of pET-28a(+) plasmid containing the decarboxylase gene to each competent cell and place them on ice for 30 minutes. Heat shock at 42℃ for 50s, then place on ice for 3min. Add 600μL of sterile LB liquid culture medium and culture at 37℃, 200rpm shaking for 1h. Pipette 200μL of the cultured bacterial solution and spread it on the LB plate culture medium containing Kana resistance (50μg/mL), and invert and culture at 37℃ overnight.
2、脱羧酶表达菌株保存2. Preservation of decarboxylase expression strains
挑取LB平板上的单菌落,接种于含有Kana抗性(50μg/mL)LB液体培养基中,37℃,200rpm摇床过夜培养,用作脱羧酶的表达菌株。向菌液中加入终体积浓度为15%的无菌丙三醇,-80℃超低温冰箱中长期保存。A single colony on the LB plate was picked and inoculated into LB liquid medium containing Kana resistance (50 μg/mL), and cultured overnight at 37°C and 200 rpm in a shaking incubator to be used as a strain expressing decarboxylase. Sterile glycerol was added to the bacterial solution at a final volume concentration of 15%, and stored in a -80°C ultra-low temperature refrigerator for a long term.
3、蛋白表达3. Protein expression
(a)种子摇瓶培养:将100μL脱羧酶蛋白表达甘油菌接种入50mL无菌TB液体培养基中,卡那霉素终浓度为50μg/mL,37℃,200rpm培养8h,得到脱羧酶蛋白表达种子瓶菌液。(b)发酵摇瓶培养:将10mL脱羧酶蛋白表达种子瓶菌液接种入350mL无菌TB液体培养基中,卡那霉素终浓度为50μg/mL,37℃,200rpm;待OD600=0.6-0.8时,加入终浓度为0.3mM 的无菌IPTG,28℃,200rpm诱导培养20h,得到酶液。(c)将酶液进行超声破壁处理,进行全菌、破壁上清液及破壁沉淀的SDS-PAGE检测,鉴定其分子量大小及可溶性表达情况。结果如图1所示。SDS-PAGE检测结果显示两种宿主中脱羧酶均表达成功,蛋白分子量约为61.3kDa,其中脱羧酶突变体在OverExpress C43(DE3)宿主中的表达量最高。(d)4000rpm离心12min 收集已大量表达脱羧酶突变体的OverExpress C43(DE3)菌体。(a) Seed shake flask culture: 100 μL of decarboxylase protein expression glycerol bacteria were inoculated into 50 mL of sterile TB liquid culture medium, the final concentration of kanamycin was 50 μg/mL, 37°C, 200 rpm culture for 8 h, and the decarboxylase protein expression seed bottle bacterial solution was obtained. (b) Fermentation shake flask culture: 10 mL of decarboxylase protein expression seed bottle bacterial solution was inoculated into 350 mL of sterile TB liquid culture medium, the final concentration of kanamycin was 50 μg/mL, 37°C, 200 rpm; when OD600 = 0.6-0.8, sterile IPTG with a final concentration of 0.3 mM was added, and the induction culture was carried out at 28°C, 200 rpm for 20 h to obtain enzyme solution. (c) The enzyme solution was subjected to ultrasonic cell wall breaking treatment, and the whole bacteria, cell wall breaking supernatant and cell wall breaking precipitate were subjected to SDS-PAGE detection to identify its molecular weight and soluble expression. The results are shown in Figure 1. The results of SDS-PAGE showed that the decarboxylase was successfully expressed in both hosts, with a protein molecular weight of about 61.3 kDa. The expression level of the decarboxylase mutant was the highest in the OverExpress C43 (DE3) host. (d) Centrifuge at 4000 rpm for 12 min to collect the OverExpress C43 (DE3) cells that had expressed a large amount of the decarboxylase mutant.
将实施例1中所获得的已大量表达脱羧酶突变体的OverExpress C43(DE3)湿菌体进行应用,具体见实施例2~6。The OverExpress C43 (DE3) wet bacteria obtained in Example 1 and expressing a large amount of decarboxylase mutants were used, as shown in Examples 2 to 6.
实施例2利用脱羧酶合成2-呋喃基羟基甲基酮Example 2 Synthesis of 2-furanyl hydroxymethyl ketone using decarboxylase
(1)2-呋喃基羟基甲基酮的合成(1) Synthesis of 2-furanyl hydroxymethyl ketone
底物溶液采用pH7.0的水溶液配制,进行流加反应,反应底物终浓度为60g/L的糠醛和甲醛,反应温度35℃,实施例1中的脱羧酶湿菌体用量为20g/L,反应6h后离心(8000rpm离心2min)获得样品水溶液,将该水溶液采用2倍的乙酸乙酯进行萃取,在60℃、真空度-0.1MPa条件下旋蒸回收乙酸乙酯获得80g 2-呋喃基羟基甲基酮产品。The substrate solution was prepared with an aqueous solution of pH 7.0, and a fed-batch reaction was carried out. The final concentration of the reaction substrate was 60 g/L of furfural and formaldehyde, the reaction temperature was 35° C., the amount of the decarboxylase wet bacteria in Example 1 was 20 g/L, and the sample aqueous solution was obtained by centrifugation (8000 rpm for 2 min) after the reaction for 6 h. The aqueous solution was extracted with 2 times of ethyl acetate, and 80 g of 2-furanyl hydroxymethyl ketone product was obtained by rotary evaporation at 60° C. and a vacuum degree of -0.1 MPa to recover ethyl acetate.
(2)2-呋喃基羟基甲基酮的检测(2) Detection of 2-furanyl hydroxymethyl ketone
将步骤1得到的样品水溶液稀释10倍以达到更好的HPLC分离效果。利用HPLC检测样品中2-呋喃基羟基甲基酮的纯度。HPLC仪器型号:岛津LC 2030C。参数设置:色谱柱:Inertsil ODS-3V(4.6×250mm);波长274nm,柱温30℃;流动相:A相为磷酸缓冲盐,磷酸二氢钾2.73g溶于1000ml水,用稀磷酸调至2.8;B相为乙腈;流速1mL/min。根据峰面积确定样品中2- 呋喃基羟基甲基酮的纯度。HPLC结果如图2所示,2-呋喃基羟基甲基酮的保留时间为4.81min,产品液相纯度为97.26%。经步骤1获得的产品进行核磁共振分析,从图3图谱解析可进一步确定反应生成的产品为目的产物2- 呋喃基羟基甲基酮。The sample aqueous solution obtained in step 1 was diluted 10 times to achieve a better HPLC separation effect. The purity of 2-furanylhydroxymethylketone in the sample was detected by HPLC. HPLC instrument model: Shimadzu LC 2030C. Parameter settings: chromatographic column: Inertsil ODS-3V (4.6×250mm); wavelength 274nm, column temperature 30℃; mobile phase: phase A is phosphate buffer, 2.73g of potassium dihydrogen phosphate is dissolved in 1000ml of water, and adjusted to 2.8 with dilute phosphoric acid; phase B is acetonitrile; flow rate 1mL/min. The purity of 2-furanylhydroxymethylketone in the sample is determined according to the peak area. The HPLC results are shown in Figure 2. The retention time of 2-furanylhydroxymethylketone is 4.81min, and the liquid phase purity of the product is 97.26%. The product obtained in step 1 was subjected to nuclear magnetic resonance analysis. From the spectrum analysis of Figure 3, it can be further determined that the product generated by the reaction is the target product 2-furanylhydroxymethylketone.
通过检测表明,本发明与现有技术文献CN114591938A相比,耗时更短,进一步提高了效率,反应6h获得液相纯度为97.26%的产品,而现有技术反应20h才能达到与97.1%的液相纯度。具体的比较见实施例7。The test shows that the present invention takes less time and further improves the efficiency compared with the prior art document CN114591938A. The product with a liquid phase purity of 97.26% is obtained after 6 hours of reaction, while the prior art reaction takes 20 hours to reach a liquid phase purity of 97.1%. See Example 7 for a specific comparison.
实施例3Example 3
底物溶液采用pH6.0的水溶液配制,进行流加反应,反应底物终浓度为60g/L的糠醛和甲醛,反应温度37℃,实施例1中的脱羧酶用量为20g/L,反应6h后离心(8000rpm离心2min)获得样品水溶液。利用HPLC检测样品中2-呋喃基羟基甲基酮的纯度,产品纯度97.23%。The substrate solution was prepared with an aqueous solution of pH 6.0, and a fed-addition reaction was performed. The final concentration of the reaction substrate was 60 g/L of furfural and formaldehyde, the reaction temperature was 37° C., the amount of the decarboxylase in Example 1 was 20 g/L, and the sample aqueous solution was obtained by centrifugation (8000 rpm for 2 min) after the reaction for 6 h. The purity of 2-furanyl hydroxymethyl ketone in the sample was detected by HPLC, and the product purity was 97.23%.
实施例4Example 4
底物溶液采用pH6.5的水溶液配制,进行流加反应,反应底物终浓度为60g/L的糠醛和甲醛,反应温度25℃,实施例1中的脱羧酶用量为20g/L,反应8h后离心(8000rpm离心2min)获得样品水溶液。利用HPLC检测样品中2-呋喃基羟基甲基酮的纯度,产品纯度97.19%。The substrate solution was prepared with an aqueous solution of pH 6.5, and a fed-addition reaction was performed, the final concentration of the reaction substrate was 60 g/L of furfural and formaldehyde, the reaction temperature was 25° C., the amount of the decarboxylase in Example 1 was 20 g/L, and the sample aqueous solution was obtained by centrifugation (8000 rpm for 2 min) after the reaction for 8 h. The purity of 2-furanyl hydroxymethyl ketone in the sample was detected by HPLC, and the product purity was 97.19%.
实施例5Example 5
底物溶液采用pH7.0的水溶液配制,进行流加反应,反应底物终浓度为55g/L的糠醛和甲醛,反应温度35℃,实施例1中的脱羧酶用量为20g/L,反应5.5h后离心(8000rpm离心2min)获得样品水溶液。利用HPLC检测样品中2-呋喃基羟基甲基酮的纯度,产品纯度97.58%。The substrate solution was prepared with an aqueous solution of pH 7.0, and a fed-addition reaction was performed, the final concentration of the reaction substrate was 55 g/L of furfural and formaldehyde, the reaction temperature was 35° C., the amount of the decarboxylase in Example 1 was 20 g/L, and the sample aqueous solution was obtained by centrifugation (8000 rpm for 2 min) after the reaction for 5.5 h. The purity of 2-furanyl hydroxymethyl ketone in the sample was detected by HPLC, and the product purity was 97.58%.
实施例6Example 6
底物溶液采用pH7.0的水溶液配制,进行流加反应,反应底物终浓度为65g/L的糠醛和甲醛,反应温度40℃,实施例1中的脱羧酶用量为20g/L,反应10h后离心(8000rpm离心2min)获得样品水溶液。利用HPLC检测样品中2-呋喃基羟基甲基酮的纯度,产品纯度97.09%。The substrate solution was prepared with an aqueous solution of pH 7.0, and a fed-addition reaction was performed, the final concentration of the reaction substrate was 65 g/L of furfural and formaldehyde, the reaction temperature was 40° C., the amount of the decarboxylase in Example 1 was 20 g/L, and the sample aqueous solution was obtained by centrifugation (8000 rpm for 2 min) after the reaction for 10 h. The purity of 2-furanyl hydroxymethyl ketone in the sample was detected by HPLC, and the product purity was 97.09%.
实施例7Example 7
将本发明的产品与现有技术中的产品进行了比较,具体的结果如下:The product of the present invention is compared with the product in the prior art, and the specific results are as follows:
表1本发明中的产品与现有技术中产品的比较表Table 1 Comparison of the products in the present invention and the products in the prior art
现有技术中的产品,是指CN114591938A所披露的羧化酶突变体。从以上表格中的数据可以看出,催化获得同类型产品的过程中,本发明的脱羧酶在催化6小时后,所获得的2-呋喃基羟基甲基酮的纯度能达到97.26%,其纯度较高,时间短。The product in the prior art refers to the carboxylase mutant disclosed in CN114591938A. From the data in the above table, it can be seen that in the process of catalyzing the same type of product, the purity of the obtained 2-furanyl hydroxymethyl ketone can reach 97.26% after 6 hours of catalysis by the decarboxylase of the present invention, which has a high purity and a short time.
而现有技术中的实施例2~4中,当催化20小时后,所获得的产品1-(2- 呋喃基)-2羟基乙酮的纯度才与本发明相当;当催化8小时后,产品的纯度为95.5,低于本发明约2个百分点。本领域技术人员所公知的是,要将产品呋喃铵盐前体即呋喃基羟基酮类产品的纯度提高哪怕1个百分点,也是非常困难的事。本发明通过新的脱羧酶催化剂使产品的纯度达到了约2个百分点,相对于现有技术具有突出的、显著的进步。In the prior art, in Examples 2 to 4, after 20 hours of catalysis, the purity of the obtained product 1-(2-furanyl)-2-hydroxyethyl ketone is comparable to that of the present invention; after 8 hours of catalysis, the purity of the product is 95.5, which is about 2 percentage points lower than that of the present invention. It is well known to those skilled in the art that it is very difficult to increase the purity of the product furan ammonium salt precursor, i.e., furanyl hydroxy ketone product, by even 1 percentage point. The present invention achieves a purity of about 2 percentage points through a new decarboxylase catalyst, which is an outstanding and significant improvement over the prior art.
序列表1Sequence Listing 1
SEQ ID NO:1SEQ ID NO:1
MTTPYTVGRYLLDRLAELGIDRLFGVPGDYNLNFLSQVMEDPVIEWVGNRNELNAAYAADGYARIKGIGALITTFGVGELS AINGVAGSYAERVPVVAITGTPATSVMAEGLLVHHSLGDGEFQHFLHAYQEVTAAQTVLQPDTAMDEIDRVLRICWYEKRPVYIALPSDVSGKPATPPQAPLLHSSGPLAPRDNAGPLVLEQILHRLASAKRPFVLADFEVDRYHAQNLVRTFIERTGLPIATLS MGKGIIDETHPQFVGVYHGALSSNELQEQITGSDCLLLIGVQLIDTITGSFTDNIDLSTVIDIHPHHTLIEGMRYEGIDMLWLLDALTRHASQHPMAHKPNPTTVPPILPADMEGPITQEHFWSRFQQFLAPHDVLIADQGTAYFGATSLVLPPGTRFIGQPLW GSIGFTLPALLGTQLADPKRRNILLIGDGSFQLTLQELSTIIRWRLHPIIILINNDGYTVERAIHGPEEAYNDIPMWSYHDIPRVFGDSTALTRQVATVRDLDEALAAVDLARDRLVFLEVMMNRMDAPDILRRLGRAMAAQNRYMTTPYTVGRYLLDRLAELGIDRLFGVPGDYNLNFLSQVMEDPVIEWVGNRNELNAAYAADGYARIKGIGALITTFGVGELS AINGVAGSYAERVPVVAITGTPATSVMAEGLLVHHSLGDGEFQHFLHAYQEVTAAQTVLQPDTAMDEIDRVLRICWYEKRPVYIALPSDVSGKPATPPQAPLLHSSGPLAPRDNAGPLVLEQILHRLASAKRPFVLADFEVDRYHAQNLVRTFIERTGLPIATLS MGKGIIDETHPQFVGVYHGALSSNELQEQITGSDCLLLIGVQLIDTITGSFTDNIDLSTVIDIHPHHTLIEGMRYEGIDMLWLLDALTRHASQHPMAHKPNPTTVPPILPADMEGPITQEHFWSRFQQFLAPHDVLIADQGTAYFGATSLVLPPGTRFIGQPLW GSIGFTLPALLGTQLADPKRRNILLIGDGSFQLTLQELSTIIRWRLHPIIILINNDGYTVERAIHGPEEAYNDIPMWSYHDIPRVFGDSTALTRQVATVRDLDEALAAVDLARDRLVFLEVMMNRMDAPDILRRLGRAMAAQNRY
序列表2Sequence Listing 2
SEQ ID NO:2SEQ ID NO:2
atgacaacaccttacaccgttggccgttatctccttgaccgcttagccgaactcggcattgatcgcctctttggagtgcccggcgattacaatctgaactttct tagccaagtcatggaagaccccgtgattgagtgggtggggaaccgcaatgaactcaatgccgcctatgccgccgatggttacgcccgcatcaaaggtatcggagcccttatcaccacatttggtgtgggggaactcagcgccatcaatggcgtcgccggatcgtatgcagaacgagtgccggtagtggccattaccggaa cacctgctacatcggtgatggccgaaggccttttagttcatcattcgttaggcgatggtgagtttcaacatttcctgcacgcgtatcaagaggtcaccgcggcgcaaaccgtgttacaaccggacaccgcgatggatgaaattgatcgcgtcttgcgaatttgttggtatgagaaacgcccggtatacattgccctcccgtcgga cgtcagtggcaaacccgcaacaccgcctcaagcgccgttacttcattcctctgggccgttggcacctcgtgataatgctggccccctggtgctcgaacagattcttcaccgtctcgcatcagcaaagcgtcccttcgtcctagccgattttgaagttgaccggtatcatgcacaaaatcttgttcggacgttcatcgaacgcactg ggctgcctattgccacattaagcatgggcaagggcattattgatgaaacgcatcctcaatttgttggggtgtatcatggagcactgagcagcaatgaacttcaagaacagatcaccggttcggactgtttgttactcattggcgtgcaactaatcgacaccatcaccggaagctttaccgataacatcgacttaagcaccgtga ttgacattcaccctcaccacaccctcattgaggggatgcgctacgaaggaatcgatatgttgtggctgctagatgccctgacccggcacgcgtcccaacaccctatggcgcataaacccaatccaaccacggtcccccctatattgcccgccgacatggaaggccccattactcaagagcacttttggtcccgatttcaacag tttttagccccccatgatgtgctcattgcagaccaaggcacggcttactttggtgcgacttctctcgtcctgccccctggtacccgcttcattggtcaacctctttggggatcgatcgggtttaccttacccgctctacttgggacgcaacttgctgatcctaagcgtcgcaatatcctactcattggagacgggtcctttcaactgac gttacaagagctttccacgattatccgttggcgtctgcacccgatcatcatcctgatcaacaacgatggctacacggttgaacgcgccatacacggccccgaagaagcctataacgacattcccatgtggagttatcacgacatccctcgtgtctttggcgacagtacagctctcacacgccaagttgccacggtgcgcgacct cgatgaggccttggctgctgtggacctagcgcgtgaccgtctcgtctttttagaagtcatgatgaaccgcatggacgcgcccgatatcttgcgccgtttaggtcgtgctatggccgcgcaaaaccgctattaa。atgacaacaccttacaccgttggccgttatctccttgaccgcttagccgaactcggcattgatcgcctctttggagtgcccggcgattacaatctgaactttct tagccaagtcatggaagaccccgtgattgagtgggtggggaaccgcaatgaactcaatgccgcctatgccgccgatggttacgcccgcatcaaaggtatcggagcccttatcaccacatttggtgtgggggaactcagcgccatcaatggcgtcgccggatcgtatgcagaacgagtgccggtagtggccattaccggaa cacctgctacatcggtgatggccgaaggccttttagttcatcattcgttaggcgatggtgagtttcaacatttcctgcacgcgtatcaagaggtcaccgcggcgcaaaccgtgttacaaccggacaccgcgatggatgaaattgatcgcgtcttgcgaatttgttggtatgagaaacgcccggtatacattgccctcccgtcgga cgtcagtggcaaacccgcaacaccgcctcaagcgccgttacttcattcctctgggccgttggcacctcgtgataatgctggccccctggtgctcgaacagattcttcaccgtctcgcatcagcaaagcgtcccttcgtcctagccgattttgaagttgaccggtatcatgcacaaaatcttgttcggacgttcatcgaacgcactg ggctgcctattgccacattaagcatgggcaagggcattattgatgaaacgcatcctcaatttgttggggtgtatcatggagcactgagcagcaatgaacttcaagaacagatcaccggttcggactgtttgttactcattggcgtgcaactaatcgacaccatcaccggaagctttaccgataacatcgacttaagcaccgtga ttgacattcaccctcaccacaccctcattgaggggatgcgctacgaaggaatcgatatgttgtggctgctagatgccctgacccggcacgcgtcccaacaccctatggcgcataaacccaatccaaccacggtcccccctatattgcccgccgacatggaaggccccattactcaagagcacttttggtcccgatttcaacag tttttagccccccatgatgtgctcattgcagaccaaggcacggcttactttggtgcgacttctctcgtcctgccccctggtacccgcttcattggtcaacctctttggggatcgatcgggtttaccttacccgctctacttgggacgcaacttgctgatcctaagcgtcgcaatatcctactcattggagacgggtcctttcaactgac gttacaagagctttccacgattatccgttggcgtctgcacccgatcatcatcctgatcaacaacgatggctacacggttgaacgcgccatacacggccccgaagaagcctataacgacattcccatgtggagttatcacgacatccctcgtgtctttggcgacagtacagctctcacacgccaagttgccacggtgcgcgacct cgatgaggccttggctgctgtggacctagcgcgtgaccgtctcgtctttttagaagtcatgatgaaccgcatggacgcgcccgatatcttgcgccgtttaggtcgtgctatggccgcgcaaaaccgctattaa.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211195258.2A CN116064495B (en) | 2022-09-28 | 2022-09-28 | THDP dependent decarboxylase and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211195258.2A CN116064495B (en) | 2022-09-28 | 2022-09-28 | THDP dependent decarboxylase and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116064495A CN116064495A (en) | 2023-05-05 |
CN116064495B true CN116064495B (en) | 2024-07-02 |
Family
ID=86175803
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211195258.2A Active CN116064495B (en) | 2022-09-28 | 2022-09-28 | THDP dependent decarboxylase and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116064495B (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2540763A (en) * | 2015-07-24 | 2017-02-01 | Evocatal Gmbh | Catalytically active protein aggregates and methods for producing the same |
CN114591938B (en) * | 2022-04-07 | 2023-07-25 | 山东金城医药研究院有限公司 | Carboxylase mutant and preparation method and application thereof |
-
2022
- 2022-09-28 CN CN202211195258.2A patent/CN116064495B/en active Active
Non-Patent Citations (1)
Title |
---|
alpha-keto acid decarboxylase family protein [Sulfobacillus sp. hq2];NCBI Reference Sequence: WP_103376266.1;《Genbank Database》;20180422;1-2 * |
Also Published As
Publication number | Publication date |
---|---|
CN116064495A (en) | 2023-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6282746B2 (en) | A polynucleotide encoding psicose epimerase and a psicose production method using the same. | |
KR102255114B1 (en) | Biosynthetic pathways and products | |
US11459592B2 (en) | Processes for the production of cannabinoids from a carbon source precursor | |
CN109266630A (en) | A kind of lipase and its preparing the application in Bu Waxitan intermediate | |
CN105176955B (en) | From the nitrilase of high mountain south mustard, gene, carrier, engineering bacteria and its application | |
CN105385700A (en) | Glucosyltransferase gene, preparation method of glucosyltransferase gene, recombinant engineering bacterium and construction method and application of recombinant engineering bacterium | |
CN114591938B (en) | Carboxylase mutant and preparation method and application thereof | |
KR101797713B1 (en) | A method for production of cinnamaldehyde | |
CN116064495B (en) | THDP dependent decarboxylase and application thereof | |
CN113462669B (en) | Ketone pantoic acid hydroxymethyl transferase mutant, coding gene and application thereof | |
CN104017795B (en) | A kind of method of utilizing the rare aldose of aldolase biosynthesis 2-deoxidation | |
EP2935577B1 (en) | Method for producing a recombinant protein of interest | |
CN109971803A (en) | A kind of L-erythrulose and erythritol production method | |
CN112961873A (en) | Method for synthesizing norepinephrine by double-enzyme coupling | |
CN116355974B (en) | Production process for synthesizing furan ammonium salt by enzyme-chemical method | |
JP5882415B2 (en) | Method for producing carbohydrates with added fructose | |
CN110951760B (en) | Protein time-delay expression switch and application thereof in production of glucaric acid | |
CN102911923B (en) | Alpha-glycosidase, coding gene, vector, engineering bacterium and application of alpha-glycosidase, coding gene, vector and engineering bacterium | |
CN114540331B (en) | Enzyme with function of catalyzing glycolaldehyde to synthesize D-erythrose and application thereof | |
JPWO2005098012A1 (en) | Method for producing chiral hydroxyaldehyde compound | |
CN111394382B (en) | Recombinant expression vector and recombinant bacterium of feruloyl esterase BpFae gene, and recombinant expression method | |
CN110467655B (en) | A protein and its application | |
WO2018121129A1 (en) | Carbonyl reductase oligomer and use thereof in synthesis of chiral alcohol | |
CN108018265A (en) | A kind of inositol oxidation enzyme mutant and its encoding gene and application | |
CN118995549A (en) | Engineering bacterium for producing glycoside hydrolase and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant |